|
Jan 5
|
Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
|
|
Jan 4
|
Liquidia Corporation Announces $100 Million in New Financings
|
|
Jan 2
|
Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 22
|
Peabody Energy, Janus International, and More Stocks See Action From Activist Investors
|
|
Dec 22
|
Industry Analysts Just Upgraded Their Liquidia Corporation (NASDAQ:LQDA) Revenue Forecasts By 38%
|
|
Dec 21
|
Independent Director of Liquidia Picks Up 5.3% More Stock
|
|
Dec 20
|
U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)
|
|
Dec 19
|
Insider Sell Alert: Chief Medical Officer Rajeev Saggar Sells 14,887 Shares of Liquidia Corp (LQDA)
|
|
Nov 28
|
Liquidia (NASDAQ:LQDA) shareholders have earned a 35% CAGR over the last three years
|
|
Nov 8
|
Liquidia Corporation (NASDAQ:LQDA) Q3 2023 Earnings Call Transcript
|
|
Nov 8
|
Q3 2023 Liquidia Corp Earnings Call
|
|
Nov 7
|
Liquidia Corp (LQDA) Reports Q3 2023 Financial Results
|
|
Nov 7
|
Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update
|
|
Jun 29
|
Liquidia (LQDA) Up on Deal With Pharmosa to Co-Develop PH Drug
|
|
Jun 28
|
Liquidia Corporation and Pharmosa Biopharm Announce Collaboration for Sustained-Release Inhaled Treprostinil Product in North America
|
|
Apr 27
|
Liquidia Corporation to Report First Quarter 2023 Financial Results on May 4, 2023
|